Cargando…
SAHA (Vorinostat) Corrects Inhibitory Synaptic Deficits Caused by Missense Epilepsy Mutations to the GABA(A) Receptor γ2 Subunit
The GABA(A) receptor (GABA(A)R) α1 subunit A295D epilepsy mutation reduces the surface expression of α1(A295D)β2γ2 GABA(A)Rs via ER-associated protein degradation. Suberanilohydroxamic acid (SAHA, also known as Vorinostat) was recently shown to correct the misfolding of α1(A295D) subunits and thereb...
Autores principales: | Durisic, Nela, Keramidas, Angelo, Dixon, Christine L., Lynch, Joseph W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876238/ https://www.ncbi.nlm.nih.gov/pubmed/29628874 http://dx.doi.org/10.3389/fnmol.2018.00089 |
Ejemplares similares
-
γ1-Containing GABA-A Receptors Cluster at Synapses Where they Mediate Slower Synaptic Currents than γ2-Containing GABA-A Receptors
por: Dixon, Christine L., et al.
Publicado: (2017) -
Effects of GABA(A) Receptor α3 Subunit Epilepsy Mutations on Inhibitory Synaptic Signaling
por: Syed, Parnayan, et al.
Publicado: (2020) -
Vorinostat (SAHA) and Breast Cancer: An Overview
por: Wawruszak, Anna, et al.
Publicado: (2021) -
Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms
por: Tu, Bo, et al.
Publicado: (2020) -
Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration
por: Wolf, Ines M. L., et al.
Publicado: (2014)